
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Innate Immune Cells: Monocytes, Monocyte-Derived Macrophages and Microglia as Therapeutic Targets for Alzheimer’s Disease and Multiple Sclerosis
Adham Fani Maleki, Serge Rivest
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 83
Adham Fani Maleki, Serge Rivest
Frontiers in Cellular Neuroscience (2019) Vol. 13
Open Access | Times Cited: 83
Showing 1-25 of 83 citing articles:
Hydrogen sulfide: An endogenous regulator of the immune system
Nahzli Dilek, Andreas Papapetropoulos, Tracy Toliver‐Kinsky, et al.
Pharmacological Research (2020) Vol. 161, pp. 105119-105119
Open Access | Times Cited: 225
Nahzli Dilek, Andreas Papapetropoulos, Tracy Toliver‐Kinsky, et al.
Pharmacological Research (2020) Vol. 161, pp. 105119-105119
Open Access | Times Cited: 225
Caspase-9: A Multimodal Therapeutic Target With Diverse Cellular Expression in Human Disease
Maria I. Avrutsky, Carol M. Troy
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 107
Maria I. Avrutsky, Carol M. Troy
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 107
COVID-19 and risk of neurodegenerative disorders: A Mendelian randomization study
Chunyu Li, Jiayan Liu, Junyu Lin, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 105
Chunyu Li, Jiayan Liu, Junyu Lin, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 105
Masitinib for mild-to-moderate Alzheimer’s disease: results from a randomized, placebo-controlled, phase 3, clinical trial
Bruno Dubois, Jesús López‐Arrieta, Stanley Lipschitz, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 54
Bruno Dubois, Jesús López‐Arrieta, Stanley Lipschitz, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 54
Targeting the Immune System for Ischemic Stroke
Shenpeng R. Zhang, Thanh G. Phan, Christopher G. Sobey
Trends in Pharmacological Sciences (2020) Vol. 42, Iss. 2, pp. 96-105
Closed Access | Times Cited: 98
Shenpeng R. Zhang, Thanh G. Phan, Christopher G. Sobey
Trends in Pharmacological Sciences (2020) Vol. 42, Iss. 2, pp. 96-105
Closed Access | Times Cited: 98
Senescent cells and macrophages: key players for regeneration?
Sonia S. Elder, Elaine Emmerson
Open Biology (2020) Vol. 10, Iss. 12
Open Access | Times Cited: 74
Sonia S. Elder, Elaine Emmerson
Open Biology (2020) Vol. 10, Iss. 12
Open Access | Times Cited: 74
The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases
Xin Zang, Si Chen, Junyao Zhu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 63
Xin Zang, Si Chen, Junyao Zhu, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 63
Efficacy and Safety of Masitinib in Progressive Forms of Multiple Sclerosis
Patrick Vermersch, Luís Brieva, Robert J. Fox, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 3
Open Access | Times Cited: 50
Patrick Vermersch, Luís Brieva, Robert J. Fox, et al.
Neurology Neuroimmunology & Neuroinflammation (2022) Vol. 9, Iss. 3
Open Access | Times Cited: 50
CD33 isoforms in microglia and Alzheimer's disease: Friend and foe
Ghazaleh Eskandari‐Sedighi, Jaesoo Jung, Matthew S. Macauley
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101111-101111
Closed Access | Times Cited: 40
Ghazaleh Eskandari‐Sedighi, Jaesoo Jung, Matthew S. Macauley
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101111-101111
Closed Access | Times Cited: 40
Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes
Dong Won Kim, Kevin J. Tu, Alice Wei, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 40
Dong Won Kim, Kevin J. Tu, Alice Wei, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 40
Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review
Alfredo Sanabria‐Castro, Alberto Alape‐Girón, Marietta Flores-Dı́az, et al.
Reviews in the Neurosciences (2024) Vol. 35, Iss. 3, pp. 355-371
Closed Access | Times Cited: 10
Alfredo Sanabria‐Castro, Alberto Alape‐Girón, Marietta Flores-Dı́az, et al.
Reviews in the Neurosciences (2024) Vol. 35, Iss. 3, pp. 355-371
Closed Access | Times Cited: 10
Genetic landscape and autoimmunity of monocytes in developing Vogt–Koyanagi–Harada disease
Youjin Hu, Yixin Hu, Yuhua Xiao, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 41, pp. 25712-25721
Open Access | Times Cited: 51
Youjin Hu, Yixin Hu, Yuhua Xiao, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 41, pp. 25712-25721
Open Access | Times Cited: 51
Circadian Clock Regulates Inflammation and the Development of Neurodegeneration
Xiaolan Wang, Lianjian Li
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 48
Xiaolan Wang, Lianjian Li
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 48
Neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio are associated with a 2-year relapse in patients with multiple sclerosis
Wei‐Chin Huang, Hui‐Chen Lin, Yao‐Hsu Yang, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 58, pp. 103514-103514
Open Access | Times Cited: 34
Wei‐Chin Huang, Hui‐Chen Lin, Yao‐Hsu Yang, et al.
Multiple Sclerosis and Related Disorders (2022) Vol. 58, pp. 103514-103514
Open Access | Times Cited: 34
Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases
Shehata Anwar, Vincent Pons, Serge Rivest
Cells (2020) Vol. 9, Iss. 7, pp. 1595-1595
Open Access | Times Cited: 48
Shehata Anwar, Vincent Pons, Serge Rivest
Cells (2020) Vol. 9, Iss. 7, pp. 1595-1595
Open Access | Times Cited: 48
Genetic Approaches Using Zebrafish to Study the Microbiota–Gut–Brain Axis in Neurological Disorders
Jae Geun Lee, Hyun-Ju Cho, Yun‐Mi Jeong, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 566-566
Open Access | Times Cited: 40
Jae Geun Lee, Hyun-Ju Cho, Yun‐Mi Jeong, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 566-566
Open Access | Times Cited: 40
Comparative Review of Microglia and Monocytes in CNS Phagocytosis
Megumi Andoh, Ryuta Koyama
Cells (2021) Vol. 10, Iss. 10, pp. 2555-2555
Open Access | Times Cited: 38
Megumi Andoh, Ryuta Koyama
Cells (2021) Vol. 10, Iss. 10, pp. 2555-2555
Open Access | Times Cited: 38
When Is a Control Not a Control? Reactive Microglia Occur Throughout the Control Contralateral Pathway of Retinal Ganglion Cell Projections in Experimental Glaucoma
James R. Tribble, Eirini Kokkali, Amin Otmani, et al.
Translational Vision Science & Technology (2021) Vol. 10, Iss. 1, pp. 22-22
Open Access | Times Cited: 33
James R. Tribble, Eirini Kokkali, Amin Otmani, et al.
Translational Vision Science & Technology (2021) Vol. 10, Iss. 1, pp. 22-22
Open Access | Times Cited: 33
Synthesis and Comprehensive in Vivo Activity Profiling of Olean-12-en-28-ol, 3β-Pentacosanoate in Experimental Autoimmune Encephalomyelitis: A Natural Remyelinating and Anti-Inflammatory Agent
Halil Şenol, Özden Özgün, Aydan Dağ, et al.
Journal of Natural Products (2023) Vol. 86, Iss. 1, pp. 103-118
Open Access | Times Cited: 16
Halil Şenol, Özden Özgün, Aydan Dağ, et al.
Journal of Natural Products (2023) Vol. 86, Iss. 1, pp. 103-118
Open Access | Times Cited: 16
The role of miRNAs in multiple sclerosis pathogenesis, diagnosis, and therapeutic resistance
Ahmed S. Doghish, Ola Elazazy, Hend H. Mohamed, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154880-154880
Closed Access | Times Cited: 16
Ahmed S. Doghish, Ola Elazazy, Hend H. Mohamed, et al.
Pathology - Research and Practice (2023) Vol. 251, pp. 154880-154880
Closed Access | Times Cited: 16
Dopamine Transmission Imbalance in Neuroinflammation: Perspectives on Long-Term COVID-19
Maria Mancini, Silvia Natoli, Fabrizio Gardoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5618-5618
Open Access | Times Cited: 14
Maria Mancini, Silvia Natoli, Fabrizio Gardoni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5618-5618
Open Access | Times Cited: 14
Toward three-dimensional in vitro models to study neurovascular unit functions in health and disease
Jérôme Robert, Tara M. Caffrey, EmilyB Button
Neural Regeneration Research (2021) Vol. 16, Iss. 11, pp. 2132-2132
Open Access | Times Cited: 28
Jérôme Robert, Tara M. Caffrey, EmilyB Button
Neural Regeneration Research (2021) Vol. 16, Iss. 11, pp. 2132-2132
Open Access | Times Cited: 28
Cause or consequence? The role of IL-1 family cytokines and receptors in neuroinflammatory and neurodegenerative diseases
Diana Boraschi, Paola Italiani, Paola Migliorini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
Diana Boraschi, Paola Italiani, Paola Migliorini, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
The dynamics of B‐cell reconstitution post allogeneic hematopoietic stem cell transplantation: A real‐world study
G.X. Zhou, Qian Zhan, Lingle Huang, et al.
Journal of Internal Medicine (2024) Vol. 295, Iss. 5, pp. 634-650
Open Access | Times Cited: 4
G.X. Zhou, Qian Zhan, Lingle Huang, et al.
Journal of Internal Medicine (2024) Vol. 295, Iss. 5, pp. 634-650
Open Access | Times Cited: 4
Shiyun Yuan, Fuxin Zhong, Tianchi Wan, et al.
The Journal of Pathology (2025)
Closed Access